Amylyx Pharmaceuticals, Inc. (AMLX) earnings
AMLX earnings moved a median of +0.86% by the close. Quarterly and annual AMLX reports and results, each read against the price at its own news timestamp. Back to the AMLX overview →
30 measured AMLX earnings events.
Where these AMLX earnings landedvs 30 measured AMLX earnings reactions
| Middle 50% of AMLX earnings reactions | -4.01% to +2.72% |
|---|---|
| Median reaction (to close) | +0.86% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 AMLX earnings events with a measured close landed between -4.01% and +2.72%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results | Press release | +10.13% | +12.98% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +10.13% | +12.98% | |
| Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -1.09% | -0.15% | |
| Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results | Press release | -1.21% | -4.88% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.21% | -4.88% | |
| Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +0.77% | +2.37% | |
| Form 10-K Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.05% | -8.49% | |
| Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results | Press release | -3.66% | -4.01% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -3.66% | -4.01% | |
| Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +0.44% | +3.31% | |
| Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results | Press release | -0.63% | -2.00% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.63% | -2.00% | |
| Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | +0.38% | +1.13% | |
| Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results | Press release | +0.00% | -10.37% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -10.37% | |
| Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | -1.37% | +0.59% | |
| Form 10-K Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.71% | +7.50% | |
| Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results | Press release | +3.17% | +9.00% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.17% | +9.00% | |
| Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 | Press release | +0.18% | +2.15% | |
| Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results | Press release | -7.30% | -5.76% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -7.30% | -5.76% | |
| Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -0.52% | +2.60% | |
| Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results | Press release | -1.69% | +2.72% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.69% | +2.72% | |
| Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 | Press release | -0.51% | +2.04% | |
| Form 10-K Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +6.77% | +12.02% | |
| Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results | Press release | +0.79% | -2.70% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.79% | -2.70% | |
| Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023 | Press release | -0.46% | +2.68% |
Keep exploring
More AMLX: analyst actions → · SEC filings → · AMLX overview →